Status:
COMPLETED
Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Acute Respiratory Distress Syndrome
Lung Diseases
Eligibility:
All Genders
13+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS.
Detailed Description
BACKGROUND: ARDS affects approximately 150,000 people in the United States each year. Despite twenty years of research into the mechanisms that cause this syndrome and numerous developments in the te...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosed with ARDS or has risk factors for ARDS; individuals will be considered at risk if they are critically ill and have trauma, sepsis, shock, pneumonia, inhalation injury, drug overdose, pancreatitis, or hypertransfusion
- Onset of ARDS must be between 7 and 28 days prior to study entry
- Since ARDS onset, bilateral infiltrates must have persisted and participants must have required continuous mechanical ventilation
Exclusion
Key Trial Info
Start Date :
March 1 1997
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00295269
Start Date
March 1 1997
End Date
September 1 2005
Last Update
May 9 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.